ArticlePloS one2025
Elucidating the structural dynamics induced by active site mutations in 3C protease of foot-and-mouth disease virus.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Foot-and-mouth disease virus 3C protease as virulence determinant plays multiple roles in cleaving viral polyprotein and host factors.Virulence · 2026Review
- Human Metapneumovirus Nucleocapsid Inhibitors Discovery for Targeting Viral Replication and Genome Encapsidation: An In Silico Approach.Journal of tropical medicine · 2026Article
- An integrated structural and immunoinformatic approach to design a multi-epitope based vaccine against the foot-and-mouth disease virus.Scientific reports · 2025Article
- Article
- Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris.Journal, genetic engineering & biotechnology · 2025Article
- Computational identification of natural inhibitors targeting GroEL inFrontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The viral replication of foot-and-mouth disease virus (FMDV) and other picornaviruses primarily depends on the successful processing of a polyprotein precursor by the enzyme 3C protease (3Cpro) at specific sites. The crucial role of 3Cpro in viral replication and pathogenesis makes it a potential target for developing novel therapeutics against foot-and-mouth disease. The β-ribbon region (residues 138-150) containing the active site residues (C142) in 3Cpro is found to be conserved and contributes significantly to substrate specificity. Moreover, experimental reports suggest that mutations at position 142, particularly C142S and C142L, exhibit different functional activities. However, the intrinsic dynamics and conformational changes induced by active-site mutations of 3Cpro remain unclear, limiting the development of novel inhibitors of 3C protease. Accordingly, we carried out molecular dynamics (MD) simulations with multiple replicates for both the WT and mutants of 3Cpro. The observed results suggest that the C142S mutant induces substantial structural transitions compared to the WT and C142L. In contrast, the essential dynamics of the mutants significantly varied from those of the WT 3Cpro. Moreover, cross-correlation analysis revealed a similar pattern of anti-correlation between the amino acid residues of the WT and C142L mutant complexes. Analysis of the betweenness centrality of the WT and the mutants from the residue interaction networks revealed common residues for intra-residual signal propagation. The results from our study suggest that the active site mutant C142S may induce conformational changes, which can cause the β-ribbon region to bend towards the catalytic pocket and inhibit the enzymatic activity. C142L substitution may also alter the β-ribbon region conformation, which may impact the substrate binding process during proteolysis, as reported in previous studies. These results can provide a better understanding of the conformational dynamic behavior of 3Cpro active-site mutants and may assist in developing potential inhibitors against foot-and-mouth disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.